171257-01-5

Basic information

• Product Name: perhydro-azepin-3-one
• Synonyms: perhydro-azepin-3-one
• CAS NO: 171257-01-5
• Molecular Formula: C6H11NO
• Molecular Weight: 113.15764
• EINECS: -0
• Mol File: 171257-01-5.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 200.2±33.0 °C(Predicted)
• Appearance: /
• Density: 0.969±0.06 g/cm3(Predicted)
• PKA: 8.35±0.20(Predicted)
• CAS DataBase Reference: perhydro-azepin-3-one(CAS DataBase Reference)
• NIST Chemistry Reference: perhydro-azepin-3-one(171257-01-5)
• EPA Substance Registry System: perhydro-azepin-3-one(171257-01-5)

Safety Data

• Hazardous Substances Data: 171257-01-5(Hazardous Substances Data)

Upstream product

• 146407-32-1 1-benzylazepan-3-one 
• 98977-38-9 ethyl (+/-)-1-(tert-butyloxycarbonyl)-3-oxoperhydroazepine-4-carboxylate 
• 2323-81-1 ethyl 5-chloropentanoate 
• 3588-17-8 trans,trans-muconic acid 
• 13042-03-0 (oxo-2 tetrahydrofurfuryl-5)-2 acetate de methyle 
• 86606-07-7 α-hydromuconic acid monomethyl ester 
• 70353-99-0 (E)-dimethyl hex-2-enedioate 
• 60551-20-4 γ-(carboxymethyl)-γ-butyrolactone 
• 2583-24-6 α-hydromuconic acid 
• 5457-44-3 dimethyl 3-oxoadipate 

Downstream Products

• 643045-39-0 C₈H₁₆N₂O 
• 124932-43-0 (R)-(+)-3-Amino-hexahydro-1H-azepin 
• 870842-23-2 3-oxoazepane-1-carboxylic acid tert-butyl ester 

Relevant articles and documents

Method for preparing beixifloxacin intermediate compound

The invention provides a method for preparing a beixifloxacin intermediate compound VI. The method comprises the steps of: reacting a compound of a formula III with an upper protective group, an aminotransferase catalying and a deprotecting group to obtain a compound shown in a formula VI. The method can be used for preparing the beixifloxacin intermediate compound VI rapidly and effectively. Rawmaterials are simple and easy to obtain, the reaction is simple and easy to operate, harsh reaction conditions are not required, a production period is short, yield of a target product is high, separation and purification of the target product are simple, optical purity is high, the method is easy to achieve mass production.

NEW PYRIDONE DERIVATIVES WITH MCH ANTAGONISTIC ACTIVITY AND MEDICAMENTS COMPRISING THESE COMPOUNDS

The present invention relates to compounds of general formula (I) wherein the groups and radicals B, k, L, U,V, W, X, Y, Z, R1, R2, have the meanings given in claim 1. Moreover the invention relates to pharmaceutical compositions containing at least one compound according to the invention. By virtue of their MCH- receptor antagonistic activity the pharmaceutical compositions according to the invention are suitable for the treatment of metabolic disorders and/or eating disorders, particularly obesity, bulimia, anorexia, hyperphagia and diabetes.